NEFL and Alzheimer disease: We also identified that plasma NFL/Aβ1–42 distinguished participants with preclinical AD from CN participants and that the difference in the plasma NFL/Aβ1–42 z-scores was greater than that for CSF p-Tau181 and CSF t-Tau concentrations in the preclinical stage of AD.